CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Subchondroplasty Procedure with AccuFilldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03494660
NCT03494660N/ACompleted
CompareCT.gov

A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Hip

Zimmer Biomet·observational·Posted Apr 11, 2018·Updated Apr 21, 2026

In Brief

An observational study evaluating Subchondroplasty Procedure with AccuFill for Subchondral Cysts and 6 related conditions. Completed, enrolled 77 participants across 6 sites.

Detailed Summary

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSubchondral Cysts, Subchondral Bone Edema, Bone Marrow Edema, Insufficiency Fractures, Avascular Necrosis of Hip, Femoroacetabular Impingement, Dysplasia; Hip
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 11, 2018
Enrollment StartMar 27, 2018
Primary CompletionOct 23, 2023
Study CompletionJan 13, 2025
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.2 years ago

Interventions

Subchondroplasty Procedure with AccuFilldevice

Injection of the commercially available flowable calcium phosphate (CaP) synthetic bone-void filler, AccuFill®, into subchondral bone defects in the hip (Subchondroplasty (SCP) Procedure).